From May 12-13 OIFE was represented by Alessandra Tolaccia at the iDR26 – the International Drug Repurposing Conference 2026 in Brussels.

The conference was an inspiring gathering of researchers, clinicians, patient advocates, and industry leaders organized by the project REMEDi4ALL.

From AI-driven discovery to patient-led innovation, the energy around faster, more accessible treatments is real.
Beyond the science, iDR26 reinforced the power of collaboration, bringing together a truly global community working toward one goal: maximizing patient benefit.

Alessandra shared the three main points she takes home from the conference:

⏩ Speed matters: Repurposing cuts years off traditional drug development timelines
🔍 Data sharing is key: Open science unlocks hidden potential in existing treatments.
🤝 Patients are partners: True innovation happens when researchers and patients co-create solutions.

Find out more about the conference here.